Soleno Therapeutics
USEntry
2018
Hold
8yr
Exit
2026
Who owns Soleno Therapeutics?
Soleno Therapeutics was owned by Abingworth through Abingworth Bioventures VI (2014 vintage) from 2018 to 2026, exited via Trade Sale.
Buyer identity available on Pro.
Hand-verified · updated 2026-07-08
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2026
More from Abingworth Bioventures VI
Other portfolio companies in the same fund.
UK
FranceMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Soleno Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Soleno Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Soleno Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue